- Home
- SEV vs OKYO Comparison
SEV vs OKYO Comparison
Compare SEV & OKYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SEV | OKYO |
|---|---|---|
| Founded | 2019 | 2007 |
| Country | United States | United Kingdom |
| Employees | 46 | N/A |
| Industry | Auto Manufacturing | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 103.2M | 83.4M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | SEV | OKYO |
|---|---|---|
| Price | $2.58 | $1.61 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $6.33 |
| AVG Volume (30 Days) | ★ 225.7K | 47.2K |
| Earning Date | 05-16-2026 | 07-18-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $17,757.14 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.29 | $1.44 |
| 52 Week High | $11.24 | $3.35 |
Technical Indicators
Market Signals| Indicator | SEV | OKYO |
|---|---|---|
| Relative Strength Index (RSI) | 40.05 | 49.09 |
| Support Level | $2.49 | $1.48 |
| Resistance Level | $3.26 | $1.73 |
| Average True Range (ATR) | 0.15 | 0.08 |
| MACD | -0.04 | 0.00 |
| Stochastic Oscillator | 12.50 | 42.25 |
Price Performance
Historical ComparisonAbout SEV Aptera Motors Corp.
Aptera Motors Corp engages in the development, production, and distribution of energy efficient solar-powered, battery-electric vehicles. The company has designed the Aptera vehicle to provide up to an estimated 40 miles per day by collecting energy from the sun and storing it in its proprietary battery pack. The company operates as a single reportable segment focused on the development of solar electric vehicles.
About OKYO OKYO Pharma Limited
OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.